Pricing Log in Create free account

Biotricity Inc. (BTCY) vs Cytosorbents Corporation (CTSO)

Biotricity Inc. and Cytosorbents Corporation are both Medical Devices companies. Biotricity Inc. is the larger, with a market value of $10.9M against $9.7M — 1.1× the size. Biotricity Inc. grew revenue faster over the last twelve months: 13.4% against 3.07%. Biotricity Inc. has the higher net margin (−21.0% vs −48.9%) and the higher return on invested capital (0.00% vs −66.9%). Across the 17 metrics below, Biotricity Inc. leads on 11 and Cytosorbents Corporation on 6.

Valuation

Metric BTCY CTSO Medical Devices median
P/E n/m n/m 23.22
P/S 0.07 0.35 2.34
P/B n/m n/m 2.33
Price to free cash flow 8.76 n/m 23.72
EV/EBITDA 11.51 n/m 11.54
EV/Sales 1.67 0.69 2.24
Earnings yield (280.00%) (141.12%) (10.09%)
Free cash flow yield 11.41% (73.00%) (8.47%)

Profitability

Metric BTCY CTSO Medical Devices median
Gross margin 81.47% 71.61% 56.01%
Operating margin 9.56% (34.74%) (15.03%)
Net margin (21.00%) (48.94%) (20.40%)
Free cash flow margin 0.99% (25.32%) (7.24%)
Return on equity 9.75% (336.17%) (15.32%)
Return on assets (57.12%) (42.38%) (19.72%)
Return on invested capital 0.00% (66.90%) (10.33%)

Growth

Metric BTCY CTSO Medical Devices median
Revenue growth (TTM) 13.41% 3.07% 8.80%
EPS growth (last fiscal year) 80.00% 65.79% 29.03%
Revenue growth, 5-year CAGR 36.43% (2.00%) 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BTCY CTSO Medical Devices median
Debt to equity (0.75) (22.96) 0.07
Current ratio 0.15 0.66 2.50
Net debt to EBITDA 10.85 (0.85) 0.49

Dividend

Metric BTCY CTSO Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BTCY CTSO Medical Devices median
Market cap 10.87m 9.65m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack